vimarsana.com
  1. Home
  2. Live Updates
  3. Marc Stapley - Breaking News

Latest Breaking News On - Marc stapley - Page 3 : vimarsana.com

Veracyte Inc (VCYT) Reports 22% Revenue Growth in 2023, Maintains Positive Cash Flow Outlook

Full-Year Revenue Hits $361.1 Million Amidst Expansion and Innovation in Diagnostic Offerings

Marc stapleyVeracyte incFinancial performanceVeracyte diagnostics platformDiagnostic productsTotal revenueAsh and cash equivalentsImpairment chargesRevenue growthFinancial discipline

Veracyte Announces Fourth Quarter and Full-Year 2023 Financial Results

Veracyte, Inc. today announced financial results for the fourth quarter and full year ended December 31, 2023. "We closed 2023 with another quarter of excellent results, driven by our Afirma and Decipher businesses," said Marc Stapley, Veracyte's.

United statesMarc stapleyGenomics incCompany formVeracyte incExchange commissionNational comprehensive cancer networkConference callAnnounces fourth quarterVeracyte diagnostics platformDecipher prostatePercepta nasal swabRegarding useAnnual reportQuarterly reportDecipher biosciences

Veracyte to Participate in the Raymond James 45th Annual Institutional Investors Conference

Veracyte to Participate in the Raymond James 45th Annual Institutional Investors Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Shayla gormanJohn leiteRaymond jamesTracy morrisMarc stapleyVeracyte incAnnual institutional investors conferenceVeracyte diagnostics platform

Veracyte to Participate in the Raymond James 45th Annual Institutional Investors Conference

Veracyte to Participate in the Raymond James 45th Annual Institutional Investors Conference
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Marc stapleyRaymond jamesJohn leiteVeracyte incAnnual institutional investorsAnnual institutional investors conferenceVeracyte diagnostics platform

Glaukos (NYSE:GKOS) Earns Buy Rating from Needham & Company LLC

Glaukos (NYSE:GKOS) Earns Buy Rating from Needham & Company LLC
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Thomas william burnsMarc stapleyPiper sandlerGlaukos corporationWells fargo companyMorgan stanleyDriehaus capital managementNeedham companySecurities exchange commissionGlaukos company profileNorges bankJpmorgan chase coInvesco ltdFree reportModerate buyStock down
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.